Tunica, HVSF "patent" is for liposome PGE1 for intraurethral delivery.
PGE1 is in fast freeze dried fat globules (liophylized liposomes). It could be storage for 6 months.
The HVSF product must be reconstituted prior to use with a "special detergent" this turn the powder into a liquid.
HVSF has a "patented" catheter to deliver the liquid into the urethra, the same way as Muse.
But since the catheter is smaller and more flexible than MUSE, then one gets less pain or is painless.
The above is what HVSF claims.
I think that they will not prevail in a patent fight (even Zonagen is
confident in their oral "patent").
Could it be posible that the HVSF patent deal with the ability of the detergent to reconstitute the powder in a viable way?
Could it be posible that it included their softer,smaller, painless catheter?
Could it be posible that their patent deal with the "liposomal" formula ? (this I strongly doubt and LIPO already won the liposome fights in court against NXTR, a poor victory but they did win).
Finally, Can Vivus claims patent infringement? There is already some court fight between Vivus and HVSF.
Vivus already defended their patent succesfully 3 times:
1. agreement with Gene Voss (original holder of prior art).
2. stop some pharmaceutical chain from comercializing a similar product (this I learnt here in the thread).
3. recent agreement with one of Vivus's own developers about the design of Muse catheter ($5 million given as per recent earnings report).
4. European challenge at some point either concluded or close to conclusion in Vivus favor. ( only I learnt here too).
Anemic HVSF needs blood first to fight engorged Vivus. That is a tough battle. Especially when HVSF is second to everybody.
Good that Irvin "the bike" Goldstein is with HVSF, very easy to counterclaim all his statements directly or indirectly about Muse efficacy. BigKNY3, no, we do not need Dr bike with Vivus.
Macrochem (MCHM), another I. Goldstein coached company, is the company with the skin gel. They are at least well financed so far. A bigger threat in those terms, but their scientific point is even weaker than HVSF (but it remains to be seen how far could they go, and there is always a chance within the realm of posibilities). They are at best two years behind in their efforts. |
